Q3 2025 Holdings
Filed 2025-11-14 | 88 holdings | $2.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $179.9M | 1,018,831 | 9.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $138.9M | 3,844,731 | 7.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $124.6M | 9,644,872 | 6.3% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $115.2M | 1,150,000 | 5.8% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $83.9M | 259,650 | 4.2% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $76.9M | 3,870,158 | 3.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $62.9M | 150,000 | 3.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $61.0M | 8,127,100 | 3.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $58.2M | 1,178,860 | 2.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $54.0M | 728,188 | 2.7% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $52.5M | 1,866,234 | 2.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $51.2M | 69,426 | 2.6% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $51.2M | 12,131,699 | 2.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $48.2M | 890,304 | 2.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $47.3M | 493,811 | 2.4% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $45.5M | 859,166 | 2.3% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $37.0M | 4,690,000 | 1.9% |
| Indivior PLC(INDV) | ORD | G4766E116 | $35.3M | 1,466,000 | 1.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $31.3M | 68,336 | 1.6% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $31.2M | 340,243 | 1.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $31.0M | 2,012,110 | 1.6% |
| Axogen Inc(AXGN) | COM | 05463X106 | $30.8M | 1,726,553 | 1.6% |
| Neuropace Inc(NPCE) | COM | 641288105 | $30.5M | 2,957,957 | 1.5% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $24.9M | 2,500,000 | 1.3% |
| Geron Corp(GERN) | COM | 374163103 | $23.7M | 17,290,000 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $22.4M | 2,422,833 | 1.1% |
| Integra Lifesciences Hldgs C(IART) | COM NEW | 457985208 | $20.6M | 1,440,818 | 1.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $19.4M | 138,000 | 1.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.2M | 626,040 | 1.0% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $16.7M | 7,309,254 | 0.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $16.1M | 647,052 | 0.8% |
| Vericel Corp(VCEL) | COM | 92346J108 | $15.7M | 497,953 | 0.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $15.7M | 7,053,942 | 0.8% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $15.5M | 210,000 | 0.8% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $14.5M | 422,055 | 0.7% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $13.9M | 537,903 | 0.7% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $13.5M | 679,000 | 0.7% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $13.4M | 500,000 | 0.7% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $12.2M | 413,500 | 0.6% |
| CG Oncology Inc(CGON) | COM | 156944100 | $11.7M | 290,000 | 0.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $11.7M | 200,000 | 0.6% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $11.0M | 375,000 | 0.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $10.9M | 148,696 | 0.5% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.8M | 738,000 | 0.5% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $10.2M | 6,325,000 | 0.5% |
| Globus MED Inc(GMED) | CL A | 379577208 | $10.1M | 176,000 | 0.5% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $9.5M | 220,000 | 0.5% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $9.3M | 330,010 | 0.5% |
| Evolus Inc(EOLS) | COM | 30052C107 | $8.9M | 1,450,000 | 0.4% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $8.3M | 935,909 | 0.4% |